NRT smoking cessation aids in Belgium is seeing a marked reversal in 2026, with retail value anticipated to fall by 8% in current terms to EUR25.2 million, diverging sharply from five years of growth, and in contrast to the more stable regional performance. Cross-border purchasing, particularly in France, where lower out-of-pocket costs prevail due to reimbursement and regulatory advantages, has redirected demand away from domestic outlets without diminishing underlying quit attempts. The emergence of reimbursed prescription treatments, such as Champix and Decigatan, has shifted demand further by attracting smokers who previously relied on over-the-counter formats, contributing to the expectation of a 10% decline in retail volumes to 58.7 million units. The highly concentrated competitive environment, with Kenvue Belgium set to rise to a 66% value share, and pharmacies dominating distribution with an 87% retail value share, leaves limited space for new entrants or alternative distribution channels. For sustained relevance, brands must address price sensitivity, reinforce healthcare professional partnerships, and invest in product innovation and digital support, as consumer preferences remain anchored in trust, convenience, and credible medical endorsement.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the NRT Smoking Cessation Aids industry in Belgium with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the NRT Smoking Cessation Aids industry in Belgium, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The NRT Smoking Cessation Aids in Belgium report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of NRT Smoking Cessation Aids in Belgium?
- Which are the leading brands in NRT Smoking Cessation Aids in Belgium?
- How are products distributed in NRT Smoking Cessation Aids in Belgium?
- How has the regulatory and operating environment for NRT Smoking Cessation Aids changed in Belgium?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for NRT Smoking Cessation Aids
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Cross-border shoppers shift demand away from domestic outlets
Prescription and non-medicated treatments attract smokers and intensify the competition
NRT gum retains leadership but faces broad-based decline
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Healthcare promotion and digital tools set to boost quitting attempts
NRT gum to maintain leadership, but all formats expected to see volume decline
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Kenvue strengthens its lead as Perrigo loses share to its broader portfolio
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies sustains leadership as healthcare guidance drives loyalty
Retail e-commerce gains modest ground but remains secondary
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
NRT Smoking Cessation Aids
- NRT Gum
- NRT Inhalators
- NRT Lozenges
- NRT Patches
- Other NRT
NRT Smoking Cessation Aids
Nicotine-based products such as gum, lozenges, patches, and inhalators used to aid smoking cessation. Exclude electronic cigarettes (e-cigarettes).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our NRT Smoking Cessation Aids research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!